🍪 The GLP Lounge uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsInternationalHas anyone dealt with france ansm? Page 5

Has anyone dealt with france ansm?

mia_MS2 Wed, Jul 2, 2025 at 6:21 PM 27 replies 1,773 viewsPage 5 of 6
BiostatsBrad
Member
456
2,345
Jul 2024
Durham, NC
Jul 5, 2025 at 7:45 PM#21

Following on from Dr.PulmRoch — and this may be the naive question:

How would you tell the difference between that and the alternative explanation?

17 17LindaRN_retired, tommy_boulder, hyun_seoul and 14 others
Reply Quote Save Share Report
MikeKY_noInsulin
Member
267
1,234
Oct 2024
Louisville, KY
Jul 6, 2025 at 2:20 PM#22
HealthEcon_DC said:
There is a difference between no evidence and evidence of no effect, and this subject is one where the two get swapped freely in both directions.

I read this differently. The confidence in this thread is running ahead of the evidence, and I would rather the uncertainty were stated than smoothed over because it is unsatisfying.

16 16hannah_MT, Dr.SportsMedIN, amy_econ_NJ and 13 others
Reply Quote Save Share Report
PurityPaulOR
Senior Member
1,890
7,890
Mar 2024
Oregon
Jul 7, 2025 at 8:55 AM#23
HealthEcon_DC said:
There is a difference between no evidence and evidence of no effect, and this subject is one where the two get swapped freely in both directions.

Correct as far as it goes. The part it does not cover is what to do when the honest answer is "not enough data", which is more often than anyone likes.

I would rather be corrected than agreed with, if it comes to it.

15 15Admin, Dr.Martinez, mike_mod and 12 others
Reply Quote Save Share Report

Sigma-Aldrich — Research-Grade Standards

Certified reference materials, analytical reagents, and research-grade standards for peptide verification. Trusted by laboratories worldwide.

Shop Reference Standards
VanRx_Mike
Member
678
2,890
May 2024
Vancouver, CA
Jul 8, 2025 at 3:29 AM#24
HealthEcon_DC said:
There is a difference between no evidence and evidence of no effect, and this subject is one where the two get swapped freely in both directions.

Bookmarking. The distinction being drawn above is the one nobody else makes. Adding it to my notes with a link back to this thread.

14 14Dr.Martinez, mike_mod, SarahChen_PharmD and 11 others
Reply Quote Save Share Report
PedsEndoPhilly
Member
345
1,890
Jun 2024
Philadelphia, PA
Jul 8, 2025 at 10:03 PM#25

Adding the clinical framing, because it changes how the question reads. The mechanism and the magnitude are separate questions. Agreeing that something happens says nothing about whether it happens enough to act on.

13 13MikeNYC_runner and 10 others
Reply Quote Save Share Report

Similar Threads

EU EMA compounding guidance — 2026 regulatory update9 replies
UK NHS GLP-1 prescribing — NICE TA875 and access guide7 replies
Australian TGA scheduling changes — peptide access 20268 replies
Canadian GLP-1 coverage — provincial formulary comparison6 replies
Purchasing GLP-1 in Mexico — legality, quality, and safety concerns6 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register